Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
- PMID: 35371305
- PMCID: PMC8965120
- DOI: 10.7150/jca.68568
Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
Abstract
Background: The role of ferroptosis in esophageal squamous cell carcinoma (ESCC) is still unclear. Methods: The association of iron metabolism and ferroptosis-related genes with the prognosis, copy number variation (CNV), TMB, and immune cell infiltration of ESCC was explored using data from the GEO and TCGA database and validated by immunofluorescence in 112 ESCC patients from our center. The potential anti-cancer drugs and compounds from the GDSC and the Connectivity Map database were also screened. Results: A total of 117 iron metabolism and ferroptosis-related genes were identified. We found the expressions of PRNP, SLC3A2, SLC39A8, and SLC39A14 negatively related to the prognosis of ESCC patients, while ATP6V0A1 and LCN2 were opposite, which was validated in 112 ESCC samples from our center. And a prognostic signature was constructed based on their expressions and Cox regression coefficient (β). The low-score group exhibited a significantly worse OS. Besides, analysis of 179 ESCC samples from GSE53625 revealed that patients of poorly differentiation, more than 60 years, T4 stage, advanced N stage, advanced stage, and adjuvant therapy also exhibited a significantly shorter OS, based on which a nomogram to predict the OS was established. Moreover, the low-score group exhibited significantly higher CNV and TMB and more frequent mutations of TP53, MUC16, and NOTCH1. Higher proportion of Macrophages M2, and lower proportion of T cells follicular helper were observed in the low-score group. We discovered that AZD7762, Sunitinib, Cytarabine, Docetaxel, Vinblastine, and Elesclomol exhibited lower IC50 in the low-score group. And 20 potential compounds were identified from the CMap database. Conclusions: Six iron metabolism and ferroptosis-related genes were associated with the prognosis, CNV, TMB, and immune cell infiltration of ESCC. Some potential anti-cancer drugs and compounds may be helpful for OS.
Keywords: Connectivity Map database; GDSC database; GEO database; TCGA database; TMB; esophageal squamous cell carcinoma.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures







Similar articles
-
Development and Validation of a Ferroptosis-Related Gene Signature and Nomogram for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma.Front Genet. 2021 Oct 26;12:697524. doi: 10.3389/fgene.2021.697524. eCollection 2021. Front Genet. 2021. PMID: 34764976 Free PMC article.
-
Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.Front Oncol. 2021 Dec 3;11:769727. doi: 10.3389/fonc.2021.769727. eCollection 2021. Front Oncol. 2021. PMID: 34926275 Free PMC article.
-
Weighted Correlation Network Analysis of Cancer Stem Cell-Related Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma.Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221117003. doi: 10.1177/15330338221117003. Technol Cancer Res Treat. 2022. PMID: 35899307 Free PMC article.
-
A Novel Ferroptosis-Related Biomarker Signature to Predict Overall Survival of Esophageal Squamous Cell Carcinoma.Front Mol Biosci. 2021 Jul 5;8:675193. doi: 10.3389/fmolb.2021.675193. eCollection 2021. Front Mol Biosci. 2021. PMID: 34291083 Free PMC article.
-
A Novel Porphyromonas gingivalis Infection-Related Inflammatory Response-Related Genes Signature Predicts the Prognosis of Esophageal Squamous Cell Carcinoma.Clin Med Insights Oncol. 2024 Sep 13;18:11795549241275666. doi: 10.1177/11795549241275666. eCollection 2024. Clin Med Insights Oncol. 2024. PMID: 39281690 Free PMC article.
Cited by
-
GALNT5 functions as a suppressor of ferroptosis and a predictor of poor prognosis in pancreatic adenocarcinoma.Am J Cancer Res. 2023 Oct 15;13(10):4579-4596. eCollection 2023. Am J Cancer Res. 2023. PMID: 37970359 Free PMC article.
-
A novel ferroptosis-related microRNA signature with prognostic value in osteosarcoma.Acta Biochim Biophys Sin (Shanghai). 2023 Nov 25;55(11):1758-1769. doi: 10.3724/abbs.2023236. Acta Biochim Biophys Sin (Shanghai). 2023. PMID: 37814812 Free PMC article.
-
Enhanced sciatic nerve regeneration by relieving iron-overloading and organelle stress with the nanofibrous P(MMD-co-LA)/DFO conduits.Mater Today Bio. 2022 Aug 6;16:100387. doi: 10.1016/j.mtbio.2022.100387. eCollection 2022 Dec. Mater Today Bio. 2022. PMID: 36042854 Free PMC article.
-
Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression.BMC Cancer. 2023 Nov 17;23(1):1120. doi: 10.1186/s12885-023-11637-0. BMC Cancer. 2023. PMID: 37978473 Free PMC article.
-
Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma.Cancer Immunol Immunother. 2024 Jun 4;73(8):141. doi: 10.1007/s00262-024-03725-2. Cancer Immunol Immunother. 2024. PMID: 38832974 Free PMC article.
References
-
- Friedmann AJ, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. NAT REV CANCER. 2019;19:405–414. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous